Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma

S Guan, B Liu, C Zhang, K-H Lee, S Sun, J Wei

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The present study was undertaken to develop an in-house enzyme-linked immunosorbent assay (ELISA) using human leukocyte antigen class II restricted epitopes to test circulating autoantibodies to CD25 as a biomarker for esophageal cancer.
Original languageEnglish
Pages (from-to)825-9
Number of pages5
JournalClinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Volume15
Issue number10
DOIs
Publication statusPublished - Oct 2013

Fingerprint Dive into the research topics of 'Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma'. Together they form a unique fingerprint.

Cite this